iiinova — where your digital self keeps evolving

ERA4TB @era4tb.bsky.social · 22/04/2026

Well done to Lindsay and Eik for representing the ERA4TB consortium!

ERA4TB @era4tb.bsky.social · 22/04/2026

Lindsay and Eik also jumped in to present the poster of Diana Angelica Aguilar Ayala (Universidad de Zaragoza) of the joint work of several WP2 teams on: “Impact assessment of inoculum size and recent modifications on the EUCAST reference method for MIC determination of anti-tuberculosis drugs”.

100

ERA4TB @era4tb.bsky.social · 22/04/2026

Lindsay presented the work of her and her colleagues on: “Developing reliable EUCAST microtiter broth assays for novel drugs targeting metabolic pathways of Mycobacterium tuberculosis”.

100

ERA4TB @era4tb.bsky.social · 22/04/2026

ERA4TB Work Package 2 members Lindsay Sonnenkalb (Forschungszentrum Borstel, Leibniz Lungenzentrum) and Eik Hoffmann (Institut Pasteur de Lille), are attending the ESCMID - European Society of Clinical Microbiology and Infectious Diseases Global Congress 2026.

210

ERA4TB @era4tb.bsky.social · 27/02/2026

On 22nd January 2026, ERA4TB partners from @nicecomms.bsky.social and Consiglio Nazionale delle Ricerche hosted a webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587". The recording is now available to view via the ERA4TB website: era4tb.org/video-library/.

era4tb.org

Video Library - ERA4TB

001

ERA4TB @era4tb.bsky.social · 19/01/2026

📣 ERA4TB webinar alert We are three days away from our joint webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587". To find out more information and to register, please click on the link below: lnkd.in/eR9CXsCJ.

001

ERA4TB @era4tb.bsky.social · 14/01/2026

📣 ERA4TB webinar alert! Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587 (via Zoom) Thursday 22nd January 2026, 1 pm - 2 pm (UK) | 2 pm - 3 pm (CET) To register for this event, please sign up via this link: lnkd.in/eWaj-4Bi

011

ERA4TB @era4tb.bsky.social · 22/12/2025

As we come to the end of 2025, ERA4TB would like to take this opportunity to wish all our partners, collaborators and followers a wonderful holiday season. We look forward to continuing our mission of developing new treatment regimens for Tuberculosis in 2026!

010

Reposted by ERA4TB

IMI AMR ACCELERATOR @amr-accelerator.bsky.social · 11/12/2025

In this latest study under @era4tb.bsky.social, researchers adopted physiologically‑based pharmacokinetic (PBPK) modelling and used a detailed computational model to project what those concentrations likely are in human lungs (both healthy and TB-infected). 👉 Read at: bit.ly/3KA2RQx

023

ERA4TB @era4tb.bsky.social · 19/12/2025

ERA4TB decided to share some of our personal highlights for 2025! To read our full year in review post, please click on the following link: lnkd.in/eEUJsw7b

000

ERA4TB @era4tb.bsky.social · 04/12/2025

Colleagues from @unizar.es and Università di Pavia also met up with Natalya Serbina from @tballiance.bsky.social Alliance and Khisi Mdluli from The Gates Foundation. Well done to our consortium members!

010

ERA4TB @era4tb.bsky.social · 04/12/2025

Giovanni Stelitano (also from, Università di Pavia) presented his own unmoderated e-poster session, on "Mycobacterium tuberculosis Tryptophan Synthase as a target for novel antitubercular drugs".

100

ERA4TB @era4tb.bsky.social · 04/12/2025

This week, we shall find out what else our consortium members got up to during the conference! Università di Pavia's Deborah Recchia, hosted an unmoderated e-poster session on "Investigating the Impact of Inoculum Size on EUCAST Methodology for MIC Mycobacterium tuberculosis determinations".

100

ERA4TB @era4tb.bsky.social · 04/12/2025

A thread 🧵 We have more updates from ERA4TB consortium members who attended The Union World Conference on Lung Health 2025. Last week, we heard from our Universidad de Zaragoza colleagues Lara Muñoz-Muñoz, Jordana Galizia, and Marie Sylvianne Radoarivelo who each hosted e-poster sessions.

101

ERA4TB @era4tb.bsky.social · 03/12/2025

Well done to Jordana, Marie Sylvianne and Lara! If you are interested in learning more about the above three e-poster presentations; please feel free to contact the mentioned colleagues. We will providing more updates from ERA4TB in the coming days!

010

ERA4TB @era4tb.bsky.social · 03/12/2025

Lara Muñoz-Muñoz (UNIZAR) presented an e-poster presentation on "The impact of phylogenetic lineage on the drug susceptibility of Mycobacterium tuberculosis".

100

ERA4TB @era4tb.bsky.social · 03/12/2025

Marie Sylvianne Rabodoarivelo presented an e-poster presentation on "In vitro characterization of GSK2556286 activity in combination with Bedaquiline and Pretomanid against M. tuberculosis"

100

ERA4TB @era4tb.bsky.social · 03/12/2025

Jordana Galizia, PhD (UNIZAR), presented an e-poster presentation on "Assessing the translational value of in vitro time-kill assays in TB drug regimens development".

100

ERA4TB @era4tb.bsky.social · 03/12/2025

A thread 🧵 ERA4TB consortium members from Università di Pavia, @unizar.es and the @tballiance.bsky.social Alliance attended The Union World Conference on Lung Health (2025) in Copenhagen, Denmark. Three of our colleagues, from @unizar.es, hosted e-poster presentations for conference attendees.

110

ERA4TB @era4tb.bsky.social · 16/10/2025

Fernando Sanz García, from @unizar.es, presented a poster on “An assay toolkit for anti-tuberculosis drugs in the hollow-fiber system”. The poster informed readers, how key optimization tests that the hollow-fibre system, should require to allow reproducibility and robustness in its results.

000

ERA4TB @era4tb.bsky.social · 16/10/2025

From the 6th October 2025 to 7th October 2025, ERA4TB consortium members from @unizar.es, @uc3m.es and @pasteurlille.bsky.social attended MYCOVLC 2025. This annual gathering of Mycobacteria-focused laboratories, based in Spain, took place at CaixaForum in Valencia.

120

Reposted by ERA4TB

IMI AMR ACCELERATOR @amr-accelerator.bsky.social · 16/10/2025

Our latest research under @era4tb.bsky.social, highlights that small adjustments in the hollow fiber assays better reflects how TB drugs really perform. Learn more through a webinar on 21 October 2025. 👉 Research paper: bit.ly/4q7jIKE 👉 Webinar registration: bit.ly/3VN3Sa5

012

ERA4TB @era4tb.bsky.social · 07/10/2025

📣 ERA4TB webinar alert! 🕒 Only one day left! ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar! Register to save your spot: tinyurl.com/ERA4TB

010

ERA4TB @era4tb.bsky.social · 06/10/2025

📣 ERA4TB webinar alert! 🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships Register here: tinyurl.com/ERA4TB

121

ERA4TB @era4tb.bsky.social · 02/10/2025

The team presented to general audience members, the #HollowFibreSystem. They explained how this innovative piece of technology, is supporting research in drug development. Well done to those involved!

000

ERA4TB @era4tb.bsky.social · 02/10/2025

On Friday 26th September 2025, #ERA4TB Consortium members from @unizar.es and Università di Padova participated at the European Researchers' Night (2025) celebrations in Zaragoza, Spain.

101

ERA4TB @era4tb.bsky.social · 01/10/2025

📣 ERA4TB Webinar Announcement! One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'. 📅 Date: 8 October 2025; 1-2pm UK time 💻 Register here: tinyurl.com/ERA4TB

132

ERA4TB @era4tb.bsky.social · 01/10/2025

After a fun round of memory games, contestants were awarded with stickers, featuring the ERA4TB logo. Well done Deborah Recchia, Maria Rosalia Pasca and the rest of our colleagues on creating such a fun and interactive experience!

000

ERA4TB @era4tb.bsky.social · 01/10/2025

The team created a poster, featuring Alessandro Stamilla in cartoon form. Using terminology tailored for a younger audience, the poster explained what the ERA4TB project is and its goal for defeating Tuberculosis (TB).

100

ERA4TB @era4tb.bsky.social · 01/10/2025

Some exciting news! #ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).

100

ERA4TB @era4tb.bsky.social · 24/09/2025

The other poster looked at Investigating Bedaquiline Mechanisms of Action and Resistance: A Focus on MmpL4/MmpL5 Siderophore Transporters and the Novel Diarylquinoline TBAJ-587 If you would like to know more about Deborah’s work with EUCAST or TBAJ-587, please reach out to us.

010

ERA4TB @era4tb.bsky.social · 24/09/2025

ERA4TB Webinar 📣 How can health systems respond to #AMR through innovation & evidence-based policy? 🌍 Join our ERA4TB webinar 🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST 🎙️ Speakers from @NICEComms & @WHO 👉 Register: tinyurl.com/ERA4TB @amr-accelerator.bsky.social @who.int @nicecomms.bsky.social

022

ERA4TB @era4tb.bsky.social · 24/09/2025

More #ERA4TB partners SIMGM Congress - Microbiology 2025! Deborah Recchia (University of Pavia) showcased two of her posters at SIMGM Congress. The first poster, focused on the optimization of European Committee on Antimicrobial Susceptibility Testing (EUCAST).

110

ERA4TB @era4tb.bsky.social · 23/09/2025

Santiago Ramon Garcia (UNIZAR), gave a presentation on ‘Optimized in-vitro tools to inform pre-clinical and clinical progression of Tuberculosis combination therapy’. The presentation was well received by attendees. Well done, Santiago!

An image of Santiago Ramon Garcia, presenting at SIMGBM Congress - Microbiology 2025.

100

ERA4TB @era4tb.bsky.social · 23/09/2025

Last week, #ERA4TB Consortium members from @unizar.es, Università di Pavia and Università di Padova attended the SIMGBM Congress - Microbiology 2025 in Rome.

ERA4TB consortium members standing outside the venue for SIMGBM Congress - Microbology 2025.

130

Reposted by ERA4TB

IMI AMR ACCELERATOR @amr-accelerator.bsky.social · 11/09/2025

@era4tb.bsky.social researchers found compounds that block TB’s ESX-1 system (used to damage immune cells) while also improving effectiveness of ethionamide. A dual-action step against drug-resistant TB. 👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw

012

ERA4TB @era4tb.bsky.social · 22/08/2025

Eik Hoffman (@pasteurlille.bsky.social ), presented at #IUSI2025 in Vienna, Austria on behalf of #ERA4TB. He discussed the host-pathogen interaction (HPI) platform (BT08) and work of partners from ERA4TB: UHC, @unizar.es, FZB, UNIPD, UPV, @uc3m.es and @cnrs.fr. Contact Eik to find out more!

130

Reposted by ERA4TB

IMI AMR ACCELERATOR @amr-accelerator.bsky.social · 29/07/2025

Last week, we got together to focus on a key part of TB research: advancing animal models. Six ERA4TB experts discussed how ethical animal models can drive better treatments for drug-resistant TB and speed up testing of new therapies. While the webinar was internal, the impact is global.

121

ERA4TB @era4tb.bsky.social · 25/07/2025

This week at #GordonResearchConference, Santiago Ramon (@unizar.es) presented his poster on how #ERA4TB has built a multi-institutional and multidisciplinary network of more than 150 highly qualified and perfectly coordinated scientists to advance new TB drugs #TBpipeline #TranslationalResearch

An image of Santiago Ramon, standing in front of his poster at the Gordon Research Conference.

122

Reposted by ERA4TB

IMI AMR ACCELERATOR @amr-accelerator.bsky.social · 22/07/2025

I was taking 23 pills every day for 10 months.” A TB survivor shared this at ERA4TB’s MDR-TB dialogue. Behind every protocol is a person. That’s why we say “people affected by TB” or “TB survivors”. Language shifts power, from object to partner. Research must listen and build with communities.

123

ERA4TB @era4tb.bsky.social · 21/07/2025

Ainhoa Quintana (@unizar.es), presented at #GordonResearchConference today, on behalf of #ERA4TB consortium. She showcased the important role that ERA4TB's #InVitroModels play in our translational framework to advance TB drug candidates through the pipeline. Contact Ainhoa to find out more!

021

ERA4TB @era4tb.bsky.social · 21/07/2025

These tools are highly standardized across ERA4TB partners, ensuring the generation of robust, comparable data to support the progression of promising drug candidates. 2/2

000

ERA4TB @era4tb.bsky.social · 21/07/2025

His work highlights how viability assays and molecular biomarkers are used as complementary tools to inform and strengthen the translational framework within ERA4TB. 1/2

100

ERA4TB @era4tb.bsky.social · 21/07/2025

Juan Calvet (@uc3m.es) presented a poster on the integration of molecular biomarkers into time-kill assays for evaluating new anti-TB drug candidates. @amr-accelerator.bsky.social @ihieurope.bsky.social #Tuberculosis #TB #TranslationalResearch #Biomarkers #TimeKillAssays

132

ERA4TB @era4tb.bsky.social · 21/07/2025

We're at the Gordon Research Conference on Tuberculosis Drug Discovery and Development. Come talk to us! #ERA4TB #TB #TranslationalResearch #DrugDevelopment

100

ERA4TB @era4tb.bsky.social · 23/06/2025

Diana Aguilar from @unizar.es presented at #ASMMicrobe on June 22, on behalf of the ERA4TB consortium. Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens. #TBSky #TBResearch #DrugDevelopment

021

ERA4TB @era4tb.bsky.social · 19/06/2025

Lara V from ERA4TB partner @uc3m.es is attending the 38th IEEE International Symposium on Computer-Based Medical Systems, held in Madrid. Lara was presenting on ‘Detection of active and latent tuberculosis with explainable deep learning ensembles’ along with her colleagues. #TBSky #TBResearch

010

ERA4TB @era4tb.bsky.social · 05/06/2025

Good luck to all the ERA4TB consortium members presenting at PAGE 2025 this week. www.page-meeting.org/default.asp?... #TBSky #TBResearch #Tuberculosis

021